The legal framework for European cervical cancer screening programmes
Language English Country Great Britain, England Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
30265313
DOI
10.1093/eurpub/cky200
PII: 5108491
Knihovny.cz E-resources
- MeSH
- Early Detection of Cancer methods standards MeSH
- Confidentiality legislation & jurisprudence MeSH
- Humans MeSH
- Uterine Cervical Neoplasms diagnosis MeSH
- Registries standards MeSH
- Policy Making MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Europe MeSH
BACKGROUND: A comprehensive legal framework needs to be developed to run the health services and to regulate the information systems required to manage and to ensure the quality of cancer screening programmes. The aim of our study was to document and to compare the status of legal basis for cervical screening registration in European countries. METHODS: An electronic questionnaire including questions on governance, decision-making structures and legal framework was developed. The primary responses were collected by September 2016. RESULTS: We sent the questionnaire to representatives of 35 European countries (28 countries of the EU, with the United Kingdom included as 4 countries; 4 EFTA member countries: Iceland, Liechtenstein, Norway, and Switzerland); responses were collected from 33 countries. The legal framework makes it possible to personally invite individuals in 29 countries (88%). Systematic screening registration in an electronic registry is legally enshrined in 23 countries (70%). Individual linkage of records between screening and cancer registries is allowed in 19 of those countries. Linkage studies involving cancer and screening registries have been conducted in 15 countries. CONCLUSION: Although the majority of EU/EFTA countries have implemented population-based screening, only half of them have successfully performed record linkage studies, which are nevertheless a key recommendation for quality assurance of the entire screening process. The European legislation is open to the possibility of using health data for these purposes; however, member states themselves must recognize the public interest to create a legal basis, which would enable all the necessary functions for high-quality cancer screening programmes.
Finnish Cancer Registry Helsinki Finland
Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic
Institute of Health Information and Statistics Praha 2 Czech Republic
MedLawconsult Den Haag The Netherlands
The Norwegain cervical cancer screening programme Cancer Registry of Norway Oslo Norway
Unit of Cancer Epidemiology Belgian Cancer Centre Sciensano Brussels Belgium
References provided by Crossref.org
Enhancing Human Biomonitoring Studies through Linkage to Administrative Registers-Status in Europe